Park Medi World Limited (PARKHOSPS) Q1 Results FY27 Preview: Date, Time, Expectations & Key Things To Watch

CompoundingAI Research Updated July 29, 2026 3 min read

Park Medi World Limited enters Q1 FY 2026-2027 following a record-breaking year, as the hospital chain navigates the early-season surge in vector-borne diseases and the implementation of revised government health scheme rates. Investors will be looking for updates on the occupancy ramp-up at the newly commissioned Panchkula facility and the margin impact of recent strategic acquisitions.

Quick Details
Results dateAugust 03, 2026
QuarterQ1 FY 2026-2027
Previous quarter revenueRs. 460.4 Cr
Previous quarter PATRs. 76.8 Cr
Previous quarter EBITDA margin27.7%
Net debt (latest quarter)Rs. 28 Cr
Market capRs. 12,083.27 Cr
CMPRs. 279.25

Park Medi World Limited Q1 Results Date and Time

The board meeting is scheduled for August 3, 2026, to consider the standalone and consolidated unaudited financial results for the quarter ending June 30, 2026.

A conference call for analysts and institutional investors is scheduled for Tuesday, August 4, 2026, at 09:00 am IST to discuss the Q1 FY27 results.

What to expect from Park Medi World Limited's Q1 FY27 results

The hospital chain is positioned for strong sequential growth in Q1 FY27, driven by the 350-bed Panchkula facility commissioned on April 10, 2026, and an early, intense seasonal surge in dengue and flu cases. Management's guidance for FY27 incorporates a 7.5% incremental EBITDA benefit from the recently revised CGHS rates, which covered 83% of the patient mix as of December 31, 2025. While new assets like the 360-bed Agra unit currently operate at 30% occupancy, they are central to the company's strategy to reach 5,460 beds by March 2028. The upcoming call will likely focus on the margin trajectory as these new facilities ramp up, alongside updates on debtor days, which stood at 129 days at the close of FY26.

Key Things To Watch

Performance vs Guidance Tracking

  • Bed capacity — 5,460 beds by March 2028 — On track with Panchkula (350) and Palam Vihar (+100) additions
  • EBITDA margin — 26-27% range — Achieved 26.5% in FY26
  • Agra unit — Rs. 90 Cr revenue and EBITDA positivity — FY27 target

Panchkula Facility Ramp-Up

  • Facility commissioned April 10, 2026, with 350 beds
  • Watch for occupancy rate and revenue contribution in the first ~2.5 months of operations

Acquisitions Integration Update

  • Four FY26 acquisitions totalling ~Rs. 335 Cr in capacity
  • Updates on integration progress for KPS Wellness, SVPD, Durha Vitrak, and Mahip Hospital

Risks and headwinds to monitor

  • High ALOS of 6.4 days compared to peer average of ~3.8 days
  • Other expenses grew 40% YoY in FY26, the fastest-growing cost line
  • Consultant-level attrition of 18.9% remains a factor for clinical continuity

Frequently Asked Questions

How did Park Medi World's revenue perform in the most recent quarter?

Revenue from operations stood at Rs. 460.4 Cr in Q4 FY26, representing 30% YoY growth from Rs. 353.9 Cr in Q4 FY25.

What is the company's current strategy regarding debt?

Management successfully reduced net debt to a negligible Rs. 28 Cr by March 31, 2026, following post-IPO debt repayment. The company now intends to fund its next phase of expansion entirely through internal accruals.

What is the status of the company's bed capacity expansion?

The company aims to grow from 3,610 beds in FY26 to 5,460 beds by FY28, with 16 hospitals currently operational. Recent additions include the 350-bed Panchkula facility commissioned in April 2026.

Is the company on track with its previously stated guidance?

Yes, the company achieved a 26.5% EBITDA margin in FY26, which is within its long-term guided range of 26-27%. Additionally, the target to become debt-free was achieved by February 2026.

Powered by CompoundingAI — AI research platform for Indian stocks, every claim cited from primary filings

Login Now